Bayer is implementing a corporate restructuring that will slash an unspecified number of jobs, particularly within management. But the strategy does not include a breakup of the conglomerate—at least ...

Faced with huge debt, the impending expiry of a crucial patent, and ongoing litigation over a horror acquisition, Bayer CEO Bill Anderson made a bold move a year ago to get his damaged company back on ...

Bayer faces a pivotal week with a US Supreme Court hearing on Roundup lawsuits and a shareholder vote on a slashed dividend, as it pursues a multi-billion dollar settlement to cap legal risks.

When Bayer unveiled a restructuring in January, the company didn’t provide specifics on the number of planned job cuts. Now, the size of the initial round of layoffs shows CEO Bill Anderson means ...

At the company’s March 5 financial news conference, Bayer CEO Bill Anderson outlined the company’s four priorities for the next two to three years: building a strong Pharmaceuticals pipeline ...

Since he took over as CEO at Bayer nine months ago, Bill Anderson had had to make tough decisions to try to get the floundering conglomerate back on track. Bayer revealed one of them on Monday, saying ...

The 162-year-old German life sciences corporations Bayer is pushing a sweeping organizational overhaul. A representative example is breaking from its traditional year-based operating model and ...